Sun Pharma reports Rs 1,985 crore net profit in Q4FY23

Sun Pharma posted a net profit of INR 1,985 crore ($266m) in Q4 FY23 due to increased specialty drug sales and strong growth in domestic formulations and emerging markets. The firm made a net loss of INR 2,277 crore in the same quarter of the previous year. The adjusted net profit for Q4 FY23, excluding exceptional items, was INR 2,156 crore. The company’s gross revenue climbed 14.3% year-on-year to INR 10,726 crore, while its EBITDA increased 19.7% YoY to INR 2,802 crore.